Next
Next
The FDA Is Giving Low-Dose Atropine a Second Chance by The Myopia Mindset
Dr. Cary Herzberg on why the surprise rejection stung, what the advisory committee will weigh, and why an approved drop changes everything for preventive eye care.
Read on Substack